Free Trial
LON:GPL

Graft Polymer (GPL) Share Price, News & Analysis

About Graft Polymer Stock (LON:GPL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
0.16
0.24
52-Week Range
N/A
Volume
4.15 million shs
Average Volume
8.69 million shs
Market Capitalization
£3.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Graft Polymer (UK) Plc is an innovative biotechnology company focused on developing intellectual property relating to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Our mission is to improve outcomes for individuals suffering from these conditions, with an initial focus on trauma-related mental health disorders, such as PTSD, which affects approximately 13 million adults in the U.S. and 20 million in US, UK, and key EU markets.

Receive GPL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Graft Polymer and its competitors with MarketBeat's FREE daily newsletter.

GPL Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

GPL Stock Analysis - Frequently Asked Questions

Shares of GPL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

Industry
Specialty Industrial Machinery
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
£-58,517,233.04
Net Margins
-755.04%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£7.75 million
Book Value
GBX 1.59 per share

Miscellaneous

Outstanding Shares
2,324,101,227
Free Float
N/A
Market Cap
£3.79 million
Optionable
Not Optionable
Beta
1.92
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (LON:GPL) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners